Atassi M Zouhair, Casali Paolo
Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Autoimmunity. 2008 Mar;41(2):123-32. doi: 10.1080/08916930801929021.
Autoimmunity is mediated by a variety of mechanisms, molecular and cellular events, and responses. Predisposition to a given autoimmune response requires the requisite allele(s) that controls antigen presentation by antigen-presenting cells for T cell recognition. Some autoimmune responses emerge following infection by a pathogen, whose protein(s) possess structural similarities in some of its epitopes to regions on proteins of the host. Thus, antibodies evoked against a pathogen might cross-react with a self-protein and act as autoantibodies, and the involved autoantigen then provides a source for persistent stimulation. Proteins to which the immune system is ordinarily self-tolerant might, if altered, elicit autoimmune responses. Ways in which self-proteins can be altered include mutations and altered expression, posttranslational modification, covalent modifications, denaturation, native disorder or misfolding. Sequestered proteins normally sheltered from immune recognition become immunogenic and targets of immune effector functions, once exposed to the immune system. Other alterations can occur because of disruption in the levels or activity of regulatory proteins. These include certain alleles of the cytotoxic T lymphocyte-associated antigen-4 gene (possibly a nonspecific exacerbating molecule of disease risk in several autoimmune diseases), the lymphoid protein tyrosine phosphatase nonreceptor type 22 gene (associated with type 1 diabetes and other autoimmune diseases), TNF-alpha (involved in chronic inflammation, autoimmunity and malignancies) and the FOXP3 gene (expressed by CD4+C25+ regulatory T cells), whose mutations can cause immune dysregulation, polyendocrinopathy and X-linked inheritance syndromes of systemic autoimmunity. An autoimmune response can also arise from natural antibodies or autoantibodies that occur independently of known immunization and are able to bind to microbial antigens, altered proteins as well as self-antigens. Natural autoantibodies possess in general a low intrinsic affinity for antigen, but can function as templates for the generation of pathogenic autoantibodies, that emerge through a process of clonal selection entailing somatic hypermutation and class switch DNA recombination, as driven by antigen.
自身免疫由多种机制、分子和细胞事件及反应介导。对特定自身免疫反应的易感性需要控制抗原呈递细胞进行抗原呈递以供T细胞识别的必需等位基因。某些自身免疫反应在病原体感染后出现,该病原体的蛋白质在其某些表位上与宿主蛋白质区域具有结构相似性。因此,针对病原体产生的抗体可能与自身蛋白质发生交叉反应并充当自身抗体,而所涉及的自身抗原随后提供持续刺激的来源。免疫系统通常对其具有自身耐受性的蛋白质,如果发生改变,可能引发自身免疫反应。自身蛋白质发生改变的方式包括突变和表达改变、翻译后修饰、共价修饰、变性、天然无序或错误折叠。通常免受免疫识别的隔离蛋白一旦暴露于免疫系统,就会变得具有免疫原性并成为免疫效应功能的靶标。其他改变可能由于调节蛋白水平或活性的破坏而发生。这些包括细胞毒性T淋巴细胞相关抗原4基因的某些等位基因(可能是几种自身免疫性疾病中疾病风险的非特异性加剧分子)、淋巴样蛋白酪氨酸磷酸酶非受体22型基因(与1型糖尿病和其他自身免疫性疾病相关)、肿瘤坏死因子-α(参与慢性炎症、自身免疫和恶性肿瘤)以及FOXP3基因(由CD4+C25+调节性T细胞表达),其突变可导致免疫失调、多内分泌腺病和系统性自身免疫的X连锁遗传综合征。自身免疫反应也可能源于天然抗体或自身抗体,它们独立于已知的免疫接种而产生,能够结合微生物抗原、改变的蛋白质以及自身抗原。天然自身抗体通常对抗原具有低内在亲和力,但可作为产生致病性自身抗体的模板,这些致病性自身抗体通过由抗原驱动的克隆选择过程产生,该过程需要体细胞超突变和类别转换DNA重组。